SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-185580
Filing Date
2022-06-30
Accepted
2022-06-30 07:31:04
Documents
14
Period of Report
2022-06-30
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d371151d8k.htm   iXBRL 8-K 26218
2 EX-99.1 d371151dex991.htm EX-99.1 11273
6 GRAPHIC g371151img001.jpg GRAPHIC 10282
  Complete submission text file 0001193125-22-185580.txt   173062

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA aura-20220630.xsd EX-101.SCH 2869
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE aura-20220630_lab.xml EX-101.LAB 17979
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aura-20220630_pre.xml EX-101.PRE 11267
8 EXTRACTED XBRL INSTANCE DOCUMENT d371151d8k_htm.xml XML 3343
Mailing Address 85 BOLTON STREET CAMBRIDGE MA 02140
Business Address 85 BOLTON STREET CAMBRIDGE MA 02140 (617)500-8864
Aura Biosciences, Inc. (Filer) CIK: 0001501796 (see all company filings)

IRS No.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40971 | Film No.: 221056521
SIC: 2836 Biological Products, (No Diagnostic Substances)